Detalhe da pesquisa
1.
Two-year efficacy and safety of erenumab in participants with episodic migraine and 2-4 prior preventive treatment failures: results from the LIBERTY study.
J Neurol Neurosurg Psychiatry
; 93(3): 254-262, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34845002
2.
Trial of Fingolimod versus Interferon Beta-1a in Pediatric Multiple Sclerosis.
N Engl J Med
; 379(11): 1017-1027, 2018 09 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-30207920
3.
Consistent control of disease activity with fingolimod versus IFN ß-1a in paediatric-onset multiple sclerosis: further insights from PARADIGMS.
J Neurol Neurosurg Psychiatry
; 91(1): 58-66, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31467033
4.
Effect of fingolimod on MRI outcomes in patients with paediatric-onset multiple sclerosis: results from the phase 3 PARADIGMS study.
J Neurol Neurosurg Psychiatry
; 91(5): 483-492, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32132224
5.
Long-term (up to 4.5 years) treatment with fingolimod in multiple sclerosis: results from the extension of the randomised TRANSFORMS study.
J Neurol Neurosurg Psychiatry
; 87(5): 468-75, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26111826
6.
Efficacy and Safety of Erenumab in Participants With Episodic Migraine in Whom 2-4 Prior Preventive Treatments Had Failed: LIBERTY 3-Year Study.
Neurology
; 102(10): e209349, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38669638
7.
Early Use of Erenumab vs Nonspecific Oral Migraine Preventives: The APPRAISE Randomized Clinical Trial.
JAMA Neurol
; 81(5): 461-470, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38526461
8.
Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis.
N Engl J Med
; 362(5): 402-15, 2010 Feb 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-20089954
9.
Fingolimod and CSF neurofilament light chain levels in relapsing-remitting multiple sclerosis.
Neurology
; 84(16): 1639-43, 2015 Apr 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-25809304
10.
Pyrroloquinoline quinone improves growth and reproductive performance in mice fed chemically defined diets.
Exp Biol Med (Maywood)
; 228(2): 160-6, 2003 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-12563022
11.
Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial.
Lancet Neurol
; 13(6): 545-56, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24685276
12.
Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis: a randomised extension of the TRANSFORMS study.
Lancet Neurol
; 10(6): 520-9, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21571593
13.
Pyrroloquinoline quinone modulates mitochondrial quantity and function in mice.
J Nutr
; 136(2): 390-6, 2006 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-16424117